Home > Education : Guide to Best Practices
ACCC's Prostate Cancer "Best Practices" Project
A Project of ACCC's Center for Provider Education
ACCC’s Center for Provider Education’s Prostate Cancer “Best Practices” Project is a new resource for community cancer programs to help develop prostate-specific cancer services in their home communities. Learn about the ongoing project here.
Archived Webinar: "Guide to Best Practices in a Comprehensive Prostate Cancer Program II"
On August 3, 2010, ACCC offered a live web presentation about best practices in a comprehensive prostate cancer program. The webinar outlined the process and structures used by community-based cancer programs to initiate and grow their successful prostate-specific programs. Learn how to open lines of communication among providers and develop a collaborative team approach to care. This webinar is made possible by sponsorship from sanofi-aventis US.
Facilitator: Mary Lou Bowers, MBA, The Pritchard Group.
Click here to access the archived webinar.
Guide to Best Practices in a Comprehensive Prostate Cancer Program
This document is designed to assist community centers by outlining the process and structures that successful community-based prostate-specific cancer programs throughout the U.S. have used to initiate and grow their prostate cancer programs. It serves as a resource for community programs in identifying the need for prostate-specific care in their communities, opening lines of communication among providers, developing a collaborative team approach to care, and providing guidance in planning and implementing a successful multidisciplinary prostate cancer program.
Download Guide to Best Practices (PDF 111 KB).
Explore Guide to Best Practices (online version)
Oncology Issues
The Journal of the Association of Community Cancer Centers
September/October 2009 Vol. 24 No. 5
Developing a Multispecialty Prostate Cancer Clinic
Log on to Members Only to enjoy unrestricted access to all Oncology Issues articles online, or become a member of the Association or subscribe to the journal.
Prostate Cancer News/Alerts
NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) and NCCN Drugs & Biologics Compendium (NCCN Compendium™) for Prostate Cancer. These NCCN Guidelines™ are currently available as Version 2.2010.
In May 2010, the NCCN Prostate Panel added sipuleucel-T as a category 1 treatment recommendation for patients with castration-recurrent prostate cancer. Sipuleucel-T is appropriate for asymptomatic or minimally symptomatic patients with ECOG performance status 0-1. It is not recommended for patients with visceral disease and a life expectancy less than 6 months.
For the complete updated versions of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) and the NCCN Drugs & Biologics Compendium (NCCN Compendium™), please visit www.NCCN.org.
Facebook
LinkedIn
Twitter
ACCCExchange Listserve